Comments on Cancer Drug Fund – by Myeloma UK17 Nov. 2013
17/11/13 – Article by our great Myeloma UK colleague Eric Low – about the Cancer Drug Fund.
“Cancer Drugs Fund: Friend and Foe?
An article by Myeloma UK Chief Executive Eric Low on the National Cancer Drugs Fund (CDF) has been published in the November edition of the Pharmafocus. Eric has been invited to write this column on a monthly basis for the magazine.
The article calls for a more effective long-term solution to the challenge of approving new cancer drugs for use on the NHS.”
The full article on page 19 of the magazine is available here:http://tinyurl.com/o676eml
We fully endorse Eric comments and views on the subject, not only because it is only a temporary measure, but also because it is not available everywhere in the UK.